Clune & Associates, Ltd. Abbott Laboratories Transaction History
Clune & Associates, Ltd.
- $400 Billion
- Q3 2025
A detailed history of Clune & Associates, Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Clune & Associates, Ltd. holds 14,680 shares of ABT stock, worth $1.9 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
14,680
Previous 14,794
0.77%
Holding current value
$1.9 Million
Previous $2.01 Billion
2.28%
% of portfolio
0.49%
Previous 0.55%
Shares
4 transactions
Others Institutions Holding ABT
# of Institutions
3,639Shares Held
1.37BCall Options Held
9.55MPut Options Held
8.28M-
Vanguard Group Inc Valley Forge, PA173MShares$22.4 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$10.1 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA61.6MShares$7.96 Billion1.4% of portfolio
-
Capital Research Global Investors Los Angeles, CA38.8MShares$5.01 Billion1.02% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $226B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...